338 related articles for article (PubMed ID: 35844859)
41. Willingness to receive COVID-19 booster dose and its associated factors in Ghana: A cross-sectional study.
Storph RP; Essuman MA; Duku-Takyi R; Akotua A; Asante S; Armah R; Donkoh IE; Addo PA
Health Sci Rep; 2023 Apr; 6(4):e1203. PubMed ID: 37064312
[TBL] [Abstract][Full Text] [Related]
42. The Relationship between Attitudes and Satisfaction Concerning the COVID-19 Vaccine and Vaccine Boosters in Urban Bangkok, Thailand: A Cross-Sectional Study.
Kunno J; Supawattanabodee B; Sumanasrethakul C; Kaewchandee C; Wanichnopparat W; Prasittichok K
Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564481
[TBL] [Abstract][Full Text] [Related]
43. The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China.
Zhang XR; Li ZJ; Fu Q; Wang JD; Huang QM; Song WQ; Xu XY; Li ZH; Mao C
BMC Public Health; 2023 Mar; 23(1):542. PubMed ID: 36949421
[TBL] [Abstract][Full Text] [Related]
44. A positive update on COVID-19 booster vaccine willingness among Danes.
Sønderskov KM; Vistisen HT; Dinesen PT; Østergaard SD
Dan Med J; 2022 Jan; 69(2):. PubMed ID: 35088699
[TBL] [Abstract][Full Text] [Related]
45. Assessing the acceptability of COVID-19 vaccine and its booster dose.
Mubarak S; A'aqoulah A; AlGhawrie H; Albalas S; Innab N
Immun Inflamm Dis; 2023 Sep; 11(9):e950. PubMed ID: 37773710
[TBL] [Abstract][Full Text] [Related]
46. COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study.
Shehab M; Alrashed F; Alfadhli A
Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 35893815
[TBL] [Abstract][Full Text] [Related]
47. Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China.
Zhou HJ; Pan L; Shi H; Luo JW; Wang P; Porter HK; Bi Y; Li M
Front Pharmacol; 2022; 13():1013485. PubMed ID: 36204240
[No Abstract] [Full Text] [Related]
48. Assessment of COVID-19 vaccine booster dose acceptance, reluctance and concerns among elderly diabetes patients in Pakistan.
Jaweed L; Ahmed Z; Ahmad SA; Imran M; Faraz S; Sahar T; Jaweed J; Maqsood MB; Ahmed S; Iqbal A; Khalid A; Ahmed S; Ishaqui AA
Pak J Pharm Sci; 2022 Jul; 35(4(Special)):1269-1274. PubMed ID: 36218106
[TBL] [Abstract][Full Text] [Related]
49. Acceptance, attitudes, and barriers of vaccine booster dose among nursing students: A multicounty survey.
Al-Mugheed K; Al Rawajfah O; Bani-Issa W; Rababa M
J Nurs Manag; 2022 Oct; 30(7):3360-3367. PubMed ID: 36064189
[TBL] [Abstract][Full Text] [Related]
50. Uptake of COVID-19 Booster Dose among Saudi Arabian Population.
Alshahrani NZ; Alsabaani AA; Ridda I; Rashid H; Alzahrani F; Almutairi TH; Alzahrani BAS; Albeshri ASS
Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888690
[No Abstract] [Full Text] [Related]
51. Applying two behavioral theories to predict the willingness to receive COVID-19 vaccine booster in the elderly: A cross-sectional study.
Wang J; Li T; Ge J; Zhou M; Walker AN; Chen J; Zhang T; Zhang K; Gu S; You H
Res Social Adm Pharm; 2023 Mar; 19(3):495-501. PubMed ID: 36357271
[TBL] [Abstract][Full Text] [Related]
52. Caregivers' Willingness to Accept Expedited Vaccine Research During the COVID-19 Pandemic: A Cross-sectional Survey.
Goldman RD; Marneni SR; Seiler M; Brown JC; Klein EJ; Cotanda CP; Gelernter R; Yan TD; Hoeffe J; Davis AL; Griffiths MA; Hall JE; Gualco G; Mater A; Manzano S; Thompson GC; Ahmed S; Ali S; Shimizu N;
Clin Ther; 2020 Nov; 42(11):2124-2133. PubMed ID: 33067013
[TBL] [Abstract][Full Text] [Related]
53. Will People Accept a Third Booster Dose of the COVID-19 Vaccine? A Cross-Sectional Study in China.
Sun Y; Dai H; Wang P; Zhang X; Cui D; Huang Y; Zhang J; Xiang T
Front Public Health; 2022; 10():914950. PubMed ID: 35903387
[TBL] [Abstract][Full Text] [Related]
54. Identifying conditions for a third dose intention of COVID-19 vaccination in college students: A fuzzy-set qualitative comparative analysis.
Gao W; Zhang Y; Yin G
Front Public Health; 2022; 10():932243. PubMed ID: 36033777
[TBL] [Abstract][Full Text] [Related]
55. Prevalence and Drivers of COVID-19 Vaccine Booster Hesitancy Among German University Students and Employees.
Attia S; Mausbach K; Klugar M; Howaldt HP; Riad A
Front Public Health; 2022; 10():846861. PubMed ID: 35462827
[TBL] [Abstract][Full Text] [Related]
56. A study on the factors influencing the intention to receive booster shots of the COVID-19 vaccine in China based on the information frame effect.
Zhu Q; Gao Y; Hu Q; Hu D; Wu X
Front Public Health; 2024; 12():1258188. PubMed ID: 38444439
[TBL] [Abstract][Full Text] [Related]
57. Medical and non-medical students' knowledge, attitude and willingness towards the COVID-19 vaccine in China: a cross-sectional online survey.
Gao L; Su S; Du N; Han Y; Wei J; Cao M; Miao Q; Wang X
Hum Vaccin Immunother; 2022 Nov; 18(5):2073757. PubMed ID: 35612817
[TBL] [Abstract][Full Text] [Related]
58. Mothers' Impressions and Beliefs About Taking a Booster Dose for COVID-19 Vaccine During Pregnancy and Lactation.
Taybeh EO; Alsharedeh R; Hamadneh S
Cureus; 2022 Dec; 14(12):e32561. PubMed ID: 36654603
[TBL] [Abstract][Full Text] [Related]
59. Investigating the tendency to use COVID-19 vaccine booster dose in Iran.
Askarian M; Kazerooni AR; Shayan Z; Karimzadeh P; Movahedi M; Hatam N
BMC Health Serv Res; 2023 Oct; 23(1):1051. PubMed ID: 37784095
[TBL] [Abstract][Full Text] [Related]
60. COVID-19 vaccine willingness prior to and during the COVID-19 vaccination rollout in Australia.
Wang B; Nolan R; Krumeich B; D'Onise K; Marshall H
Hum Vaccin Immunother; 2022 Nov; 18(5):2079345. PubMed ID: 35675106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
